CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-17 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise | +9,913 | 63,600 | ||
| 2025-11-17 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −9,913 | 0 | ||
| 2025-11-17 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −9,913 | 0 | ||
| 2025-11-17 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise | +3,966 | 25,176 | ||
| 2025-11-17 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise | +3,966 | 29,142 | ||
| 2025-11-17 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise · Restricted Stock Units | −3,966 | 0 | ||
| 2025-11-17 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise · Restricted Stock Units | −3,966 | 0 | ||
| 2025-11-10 | Daly James M Director | Sale | −30,000 | $22.37 | $671K | 4,041 |
| 2025-09-15 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sale | −3,498 | $23.65 | $83K | 43,447 |
| 2025-09-12 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Grant or award | +6,815 | 46,945 | ||
| 2025-09-02 | GAROFALO ELIZABETH A. Director | Sale | −1,600 | $25.98 | $42K | 25,382 |
| 2025-08-18 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −22,000 | $25.18 | $554K | 40,130 |
| 2025-06-04 | Brege Laura Director | Sale | −14,446 | $21.78 | $315K | 15,095 |
| 2025-05-29 | SOLAND DANIEL B Director | Option exercise | +9,387 | 44,041 | ||
| 2025-05-29 | SOLAND DANIEL B Director | Option exercise · Restricted Stock Units | −9,387 | 0 | ||
| 2025-05-29 | SOLAND DANIEL B Director | Grant or award · Director Stock Options (Right to Buy) | +13,793 | 13,793 | ||
| 2025-05-29 | SOLAND DANIEL B Director | Grant or award · Restricted Stock Units | +8,107 | 8,107 | ||
| 2025-05-29 | Ndu Adora Director | Option exercise | +9,387 | 24,801 | ||
| 2025-05-29 | Ndu Adora Director | Option exercise · Restricted Stock Units | −9,387 | 0 | ||
| 2025-05-29 | Ndu Adora Director | Grant or award · Director Stock Options (Right to Buy) | +13,793 | 13,793 |
Page 6 of 49 · 979 trades